Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 11
2021 21
2022 40
2023 29
2024 5

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 38465007

101 results

Results by year

Filters applied: . Clear all
Page 1
Five successive waves of SARS-CoV-2 infection in the Central African Republic: a prospective observational study from 2020-2022.
Rafaï CD, Heredeibona LS, Lango-Yaya E, Belizaire RD, Senzongo O, Mbala P, Fa-Ti-Gbia MO, Bengba JA, Pounguinza S, Kandou JEK, Gonessa DY, Koyaweda W, Vickos U, Kalla GC, Nambei WS, Somse P, Bélec L, Grésenguet G, Koffi B, Mbopi-Keou FX. Rafaï CD, et al. Pan Afr Med J. 2023 Dec 28;46:120. doi: 10.11604/pamj.2023.46.120.39511. eCollection 2023. Pan Afr Med J. 2023. PMID: 38465007 Free PMC article.
COVID-19 Genomic Surveillance in Bangui (Central African Republic) Reveals a Landscape of Circulating Variants Linked to Validated Antiviral Targets of SARS-CoV-2 Proteome.
Vickos U, Camasta M, Grandi N, Scognamiglio S, Schindler T, Belizaire MRD, Lango-Yaya E, Koyaweda GW, Senzongo O, Pounguinza S, Estimé KKJF, N'yetobouko S, Gadia CLB, Feiganazoui DA, Le Faou A, Orsini M, Perno CF, Zinzula L, Rafaï CD. Vickos U, et al. Viruses. 2023 Nov 24;15(12):2309. doi: 10.3390/v15122309. Viruses. 2023. PMID: 38140550 Free PMC article.
Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational study.
Eyre DW, Futschik M, Tunkel S, Wei J, Cole-Hamilton J, Saquib R, Germanacos N, Dodgson AR, Klapper PE, Sudhanva M, Kenny C, Marks P, Blandford E, Hopkins S, Peto TEA, Fowler T. Eyre DW, et al. Lancet Infect Dis. 2023 Aug;23(8):922-932. doi: 10.1016/S1473-3099(23)00129-9. Epub 2023 Mar 28. Lancet Infect Dis. 2023. PMID: 37001541 Free PMC article.
Epidemiological Comparison of Four COVID-19 Waves in the Democratic Republic of the Congo, March 2020-January 2022.
Otshudiema JO, Folefack GLT, Nsio JM, Mbala-Kingebeni P, Kakema CH, Kosianza JB, Mfumu AK, Saidi GN, Kabongo PM, Okum R, Tshimbombu TN, Ahuka-Mundeke S, Karamagi HC, Muyembe JT, Djiguimde AP. Otshudiema JO, et al. J Epidemiol Glob Health. 2022 Sep;12(3):316-327. doi: 10.1007/s44197-022-00052-6. Epub 2022 Aug 3. J Epidemiol Glob Health. 2022. PMID: 35921045 Free PMC article.
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB, Franks B, Goodale BM, van de Wijgert J, Montes S, Veen D, Fredslund EK, Rispens T, Risch L, Dowling AV, Folarin AA, Bruijning P, Dobson R, Heikamp T, Klaver P, Cronin M, Grobbee DE; COVID-RED Consortium. Brakenhoff TB, et al. Trials. 2021 Oct 11;22(1):694. doi: 10.1186/s13063-021-05643-5. Trials. 2021. PMID: 34635140 Free PMC article.
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB, Franks B, Goodale BM, van de Wijgert J, Montes S, Veen D, Fredslund EK, Rispens T, Risch L, Dowling AV, Folarin AA, Bruijning P, Dobson R, Heikamp T, Klaver P, Cronin M, Grobbee DE; COVID-RED Consortium. Brakenhoff TB, et al. Trials. 2021 Jun 22;22(1):412. doi: 10.1186/s13063-021-05241-5. Trials. 2021. PMID: 34158099 Free PMC article.
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
Chaccour C, Ruiz-Castillo P, Richardson MA, Moncunill G, Casellas A, Carmona-Torre F, Giráldez M, Mota JS, Yuste JR, Azanza JR, Fernández M, Reina G, Dobaño C, Brew J, Sadaba B, Hammann F, Rabinovich R. Chaccour C, et al. Trials. 2020 Jun 8;21(1):498. doi: 10.1186/s13063-020-04421-z. Trials. 2020. PMID: 32513289 Free PMC article.
101 results